You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

CLINICAL TRIALS PROFILE FOR NUCALA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for NUCALA

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03292588 ↗ A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children Completed GlaxoSmithKline Phase 2 2017-11-07 The purpose of this study is to see if treatment with a medication called Nucala® (mepolizumab), given along with standard asthma care, makes children less likely to have asthma attacks.
NCT03292588 ↗ A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children Completed Inner-City Asthma Consortium Phase 2 2017-11-07 The purpose of this study is to see if treatment with a medication called Nucala® (mepolizumab), given along with standard asthma care, makes children less likely to have asthma attacks.
NCT03292588 ↗ A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children Completed Rho Federal Systems Division, Inc. Phase 2 2017-11-07 The purpose of this study is to see if treatment with a medication called Nucala® (mepolizumab), given along with standard asthma care, makes children less likely to have asthma attacks.
NCT03292588 ↗ A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children Completed National Institute of Allergy and Infectious Diseases (NIAID) Phase 2 2017-11-07 The purpose of this study is to see if treatment with a medication called Nucala® (mepolizumab), given along with standard asthma care, makes children less likely to have asthma attacks.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for NUCALA

Condition Name

Condition Name for NUCALA
Intervention Trials
Asthma 3
Chronic Rhinosinusitis With Nasal Polyps 2
Hemophagocytic Syndrome 1
Chronic Cough 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for NUCALA
Intervention Trials
Asthma 3
Nasal Polyps 2
Lymphohistiocytosis, Hemophagocytic 1
Esophagitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for NUCALA

Trials by Country

Trials by Country for NUCALA
Location Trials
United States 14
China 2
Australia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for NUCALA
Location Trials
Illinois 2
Utah 1
North Carolina 1
Minnesota 1
Florida 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for NUCALA

Clinical Trial Phase

Clinical Trial Phase for NUCALA
Clinical Trial Phase Trials
Phase 4 4
Phase 2 2
Phase 1 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for NUCALA
Clinical Trial Phase Trials
Not yet recruiting 6
Recruiting 4
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for NUCALA

Sponsor Name

Sponsor Name for NUCALA
Sponsor Trials
GlaxoSmithKline 7
Mayo Clinic 2
National Institute of Allergy and Infectious Diseases (NIAID) 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for NUCALA
Sponsor Trials
Other 14
Industry 10
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.